Catherine Saint-Laurent Thibault

Publication Activity (10 Years)

Years Active: 2017-2017
Publications (10 Years): 3

Top Topics

Ulcerative Colitis

Hepatitis C Virus Infection

Combination Therapy

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, Bruce Sill, Shalini Hede, Yong Yuan, Boris Gorsh
Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. Journal of medical economics 20 (7) (2017)
Catherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, Bruce Sill, Shalini Hede, Yong Yuan, Boris Gorsh
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. Journal of medical economics 20 (11) (2017)
Sean Stern, Alexandra J Ward, Catherine Saint-Laurent Thibault, Fernando Camacho, Elham Rahme, Dominik Naessens, Guy Aumais, Edmond-Jean Bernard, Raymond Bourdages, Albert Cohen, Pierre Pare, Peter Dyrda
Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation. Journal of medical economics 21 (1) (2017)